Search alternatives:
point decrease » point increase (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
ex decrease » _ decrease (Expand Search), nn decrease (Expand Search), we decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
i ex » i e (Expand Search), i x (Expand Search)
point decrease » point increase (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
ex decrease » _ decrease (Expand Search), nn decrease (Expand Search), we decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
i ex » i e (Expand Search), i x (Expand Search)
-
801
-
802
PRMT5 activity aids in the sustained accumulation of lipid droplets during Mtb infection.
Published 2022Subjects: -
803
-
804
Flow cytometry plots and gating strategy for phagocytic immune cells from IR damaged parotid glands.
Published 2024Subjects: -
805
-
806
-
807
Flow cytometry plots and gating strategy for lymphocytes in IR damaged parotid glands.
Published 2024Subjects: -
808
-
809
-
810
CD4+CD8+ double positive T cells significantly increase at day 30 following IR.
Published 2024Subjects: -
811
-
812
-
813
-
814
Pharmacokinetic and <i>ex vivo</i> pharmacodynamic properties of anti-C5 antibodies in <i>C5</i><sup><i>hu/hu</i></sup> mice.
Published 2020“…<p>(A) Serum concentrations of antibodies were measured by ELISA at 6 hours, 1, 2, 3, 7, 10, 13, 21, 30, 45 and 59 days post dosing in <i>C5</i><sup><i>hu/hu</i></sup> mice administered a single 15 mg/kg subcutaneous dose of anti-C5 mAbs or IgG4<sup>P</sup> control antibody (n = 5). …”
-
815
-
816
-
817
-
818
-
819
-
820